Cyclerion Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYCN and other ETFs, options, and stocks.

About CYCN

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. 

CEO
Peter M. Hecht, PhD
CEOPeter M. Hecht, PhD
Employees
1
Employees1
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2018
Founded2018
Employees
1
Employees1

CYCN Key Statistics

Market cap
9.49M
Market cap9.49M
Price-Earnings ratio
-0.39
Price-Earnings ratio-0.39
Dividend yield
—
Dividend yield—
Average volume
5.12K
Average volume5.12K
High today
$3.50
High today$3.50
Low today
$3.15
Low today$3.15
Open price
$3.33
Open price$3.33
Volume
3.25K
Volume3.25K
52 Week high
$6.80
52 Week high$6.80
52 Week low
$1.75
52 Week low$1.75
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.